These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 19384678)
1. Trazodone generates m-CPP: in 2008 risks from m-CPP might outweigh benefits of trazodone. Kast RE World J Biol Psychiatry; 2009; 10(4 Pt 2):682-5. PubMed ID: 19384678 [TBL] [Abstract][Full Text] [Related]
2. Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPgammaS binding. Odagaki Y; Toyoshima R; Yamauchi T J Psychopharmacol; 2005 May; 19(3):235-41. PubMed ID: 15888508 [TBL] [Abstract][Full Text] [Related]
3. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes. Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345 [TBL] [Abstract][Full Text] [Related]
4. Detection of novel reactive metabolites of trazodone: evidence for CYP2D6-mediated bioactivation of m-chlorophenylpiperazine. Wen B; Ma L; Rodrigues AD; Zhu M Drug Metab Dispos; 2008 May; 36(5):841-50. PubMed ID: 18238857 [TBL] [Abstract][Full Text] [Related]
5. Plasma levels of m-chlorophenylpiperazine following single oral dose administration of m-chlorophenylpiperazine and trazodone in human volunteers. Lawlor BA; Radcliffe J; Martinez R; Sunderland T; Murphy DL Biol Psychiatry; 1997 Mar; 41(6):756-7. PubMed ID: 9067003 [No Abstract] [Full Text] [Related]
6. HPLC analysis of the antidepressant trazodone and its main metabolite m-CPP in human plasma. Mercolini L; Colliva C; Amore M; Fanali S; Raggi MA J Pharm Biomed Anal; 2008 Aug; 47(4-5):882-7. PubMed ID: 18400445 [TBL] [Abstract][Full Text] [Related]
7. Preliminary study of the biotransformation of two new drugs, trazodone and etoperidone. Melzacka M; Rurak A; Vetulani J Pol J Pharmacol Pharm; 1980; 32(4):551-6. PubMed ID: 7255270 [TBL] [Abstract][Full Text] [Related]
8. Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT2C receptor levels in the rat. Fone KC; Austin RH; Topham IA; Kennett GA; Punhani T Br J Pharmacol; 1998 Apr; 123(8):1707-15. PubMed ID: 9605579 [TBL] [Abstract][Full Text] [Related]
9. Effect of dosage and route of administration of trazodone on cerebral concentration of 1-m-chlorophenylpiperazine in rats. Kinetics of trazodone biotransformation in rats. Rurak A; Melzacka M Pol J Pharmacol Pharm; 1983; 35(3):241-7. PubMed ID: 6622303 [TBL] [Abstract][Full Text] [Related]
10. Extended-release trazodone (Oleptro) for depression. Med Lett Drugs Ther; 2010 Nov; 52(1351):91-2. PubMed ID: 21068704 [TBL] [Abstract][Full Text] [Related]
11. Behavioral effects of 1-(m-chlorophenyl)piperazine (m-CPP) in a rat model of tardive dyskinesia. Samad N; Haleem MA; Haleem DJ Pak J Pharm Sci; 2008 Jul; 21(3):262-8. PubMed ID: 18614422 [TBL] [Abstract][Full Text] [Related]
12. Herb-drug interaction of silymarin or silibinin on the pharmacokinetics of trazodone in rats. Chang JC; Wu YT; Lee WC; Lin LC; Tsai TH Chem Biol Interact; 2009 Dec; 182(2-3):227-32. PubMed ID: 19765569 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of trazodone metabolism by thioridazine in humans. Yasui N; Otani K; Kaneko S; Ohkubo T; Osanai T; Ishida M; Mihara K; Kondo T; Sugawara K; Fukushima Y Ther Drug Monit; 1995 Aug; 17(4):333-5. PubMed ID: 7482685 [TBL] [Abstract][Full Text] [Related]
14. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone. Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317 [TBL] [Abstract][Full Text] [Related]
15. Increases in plasma concentration of m-chlorophenylpiperazine, but not trazodone, with low-dose haloperidol. Mihara K; Otani K; Ishida M; Yasui N; Suzuki A; Ohkubo T; Osanai T; Kaneko S; Sugawara K Ther Drug Monit; 1997 Feb; 19(1):43-5. PubMed ID: 9029745 [TBL] [Abstract][Full Text] [Related]
16. Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients. Mihara K; Yasui-Furukori N; Kondo T; Ishida M; Ono S; Ohkubo T; Osanai T; Sugawara K; Otani K; Kaneko S Ther Drug Monit; 2002 Aug; 24(4):563-6. PubMed ID: 12142643 [TBL] [Abstract][Full Text] [Related]
17. Tardive dystonia and tardive sensory syndrome related to trazodone: a case report. Lin CC; Lin PY; Lee Y; Chang YY; Chen CH Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1609-10. PubMed ID: 18562067 [No Abstract] [Full Text] [Related]
18. Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine. Maes M; Westenberg H; Vandoolaeghe E; Demedts P; Wauters A; Neels H; Meltzer HY J Clin Psychopharmacol; 1997 Oct; 17(5):358-64. PubMed ID: 9315986 [TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder. Pigott TA; L'Heureux F; Rubenstein CS; Bernstein SE; Hill JL; Murphy DL J Clin Psychopharmacol; 1992 Jun; 12(3):156-62. PubMed ID: 1629380 [TBL] [Abstract][Full Text] [Related]
20. Trazodone-induced cardiac arrhythmias: a report of two cases. Winkler D; Ortner R; Pjrek E; Aschauer H; Kasper S Hum Psychopharmacol; 2006 Jan; 21(1):61-2. PubMed ID: 16389666 [No Abstract] [Full Text] [Related] [Next] [New Search]